Document is current
Any future updates will be listed below
-
Authors
Lu, Minglei
Liang, Minting
Pan, Junkang
Zhong, Yingying
Zhang, Chunguo
Cui, Xiping
Wang, Tiantian
Yan, Jinfeng
Ding, Jinlong
Zhao, Suqing https://orcid.org/0000-0002-8458-671X
-
Funding
Funding for this research was provided by:
Guangzhou Science and Technology Foundation (201902010430100011)
Guangzhou Science and Technology Foundation (201911845027)
Guangzhou Science and Technology Foundation (2016201604030025)
Guangzhou Science and Technology Foundation (201903010034)
Guangdong Science and Technology Foundation (2017A050501034)
Guangdong Science and Technology Foundation (2018A030313926)
Science and Technology Foundation Key R&D Program of Guangdong Province (2019B020209009)
Science and Technology Foundation Key R&D Program of Guangdong Province (2019B020218009)
R&D Program of Guangdong Province Drug Administration (2021TDZ09)
R&D Program of Guangdong Province Drug Administration (2021YDZ06)
- License Information
-
More Information
Article History
Received: 6 July 2020
Accepted: 3 October 2021
First Online: 17 October 2021
Declarations
:
: This article does not contain any studies with human subjects. Code of ethics (the Guangdong Animal Center guidelines) for all animal experiments with regard to preparing antibodies were performed.
: Not applicable.
: Minglei Lu declares that he/she has no conflict of interest. Minting Liang declares that he/she has no conflict of interest. Junkang Pan declares that he/she has no conflict of interest. Yingying Zhong declares that he/she has no conflict of interest. Chunguo Zhang declares that he/she has no conflict of interest. Xiping Cui declares that he/she has no conflict of interest. Tiantian Wang declares that he/she has no conflict of interest. Jinfeng Yan declares that he/she has no conflict of interest. Jinlong Ding declares that he/she has no conflict of interest. Suqing Zhao declares that he/she has no conflict of interest.
